Overdue moms: new drug may cut C-Section risk
NCT ID NCT00930618
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a medicine called isosorbide mononitrate, given to help soften the cervix, could reduce the need for C-sections in first-time mothers whose pregnancies went past 41 weeks. Over 1,400 women took part. The goal was to see if this outpatient treatment could safely lower C-section rates and improve birth outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NULLIPARITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Robert Debré Hospital
Paris, 75019, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.